{"id":"W2141111992","doi":"10.1056/nejmoa0706383","title":"B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":2399,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"GlaxoSmithKline; Biogen; Eisai; Sanofi; Teva Pharmaceutical Industries; Genentech; AstraZeneca","keywords":"Medicine; Rituximab; Placebo; Multiple sclerosis; Internal medicine; Gastroenterology; Adverse effect; Clinical endpoint; CD20; Magnetic resonance imaging; Relapsing remitting; Surgery; Clinical trial; Immunology; Pathology; Lymphoma; Radiology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001535419,0.0007134328,0.001729903,0.0004033183,0.0002399052,0.000316842,0.0005984585,0.0006394882,0.001309754],"category_scores_gemma":[0.001122118,0.0002352217,0.0003594069,0.000282754,0.0005024452,0.0003144092,0.0002773976,0.001106218,0.0003417095],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003016528,"about_ca_system_score_gemma":0.0003056579,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002849243,"about_ca_topic_score_gemma":0.0004701947,"domain_scores_codex":[0.9994392,0.0002982917,0.00005685672,0.00006130307,0.0000796807,0.00006463629],"domain_scores_gemma":[0.999572,0.0001490838,0.0001186646,0.00003356183,0.00002708034,0.00009966125],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2705175,0.02921244,0.01480411,0.00380958,0.002588304,0.001051876,0.0006505006,0.00449165,0.1191577,0.0003336581,0.003576986,0.5498059],"study_design_scores_gemma":[0.3618824,0.5255669,0.06832404,0.0005174668,0.001471568,0.003172985,0.0001323585,0.003249468,0.02453599,0.0007207778,0.01035098,0.00007506567],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9837618,0.01452016,0.0004066903,0.0002214615,0.00006427967,0.0002641873,0.00003771649,0.00004981716,0.0006739915],"genre_scores_gemma":[0.9936941,0.004154399,0.0008738246,0.0004130682,0.000174738,0.0002844078,0.0001208914,0.000007956062,0.0002766509],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001729903,"threshold_uncertainty_score":0.008120179,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07419576150057383,"score_gpt":0.2794389112804177,"score_spread":0.2052431497798439,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}